These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17671718)

  • 1. siRNA directed against TrkA sensitizes human pancreatic cancer cells to apoptosis induced by gemcitabine through an inactivation of PI3K/Akt-dependent pathway.
    Liu D; Zhang Y; Dang C; Ma Q; Lee W; Chen W
    Oncol Rep; 2007 Sep; 18(3):673-7. PubMed ID: 17671718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway.
    Yao J; Qian C
    Med Oncol; 2010 Sep; 27(3):1017-22. PubMed ID: 19816816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    J Am Coll Surg; 2004 Jun; 198(6):953-9. PubMed ID: 15194078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA directed against survivin enhances pancreatic cancer cell gemcitabine chemosensitivity.
    Liu WS; Yan HJ; Qin RY; Tian R; Wang M; Jiang JX; Shen M; Shi CJ
    Dig Dis Sci; 2009 Jan; 54(1):89-96. PubMed ID: 18594980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.
    Duxbury MS; Ito H; Benoit E; Waseem T; Ashley SW; Whang EE
    Clin Cancer Res; 2005 May; 11(9):3433-8. PubMed ID: 15867245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.
    Cao J; Yang J; Ramachandran V; Arumugam T; Deng D; Li Z; Xu L; Logsdon CD
    PLoS One; 2015; 10(12):e0144969. PubMed ID: 26709920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRG1 promotes chemoresistance of pancreatic cancer cells through crosstalking with Akt signalling.
    Liu X; Tian X; Wang F; Ma Y; Kornmann M; Yang Y
    Eur J Cancer; 2014 Sep; 50(13):2251-62. PubMed ID: 24953335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.
    Wang M; Lu X; Dong X; Hao F; Liu Z; Ni G; Chen D
    World J Surg Oncol; 2015 Feb; 13():66. PubMed ID: 25880226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of pancreatic cancer cell apoptosis and enhancement of gemcitabine sensitivity by RAP80 siRNA.
    Li Y; Gu WJ; Liu HL
    Dig Dis Sci; 2012 Aug; 57(8):2072-8. PubMed ID: 22573342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D; Niu M; Jiao X; Zhang K; Liang J; Zhang D
    Int J Mol Sci; 2012; 13(1):1186-1208. PubMed ID: 22312312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.
    Liau SS; Whang E
    Clin Cancer Res; 2008 Mar; 14(5):1470-7. PubMed ID: 18316571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Down-regulation of Notch1 by small interfering RNA enhances chemosensitivity to gemcitabine in pancreatic cancer cells through activating apoptosis activity].
    Du X; Wang YH; Wang ZQ; Cheng Z; Li Y; Hu JK; Chen ZX; Zhou ZG
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 May; 43(3):313-8. PubMed ID: 24998655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer.
    Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y
    Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways.
    Li J; Liang X; Yang X
    Oncol Rep; 2012 Aug; 28(2):501-10. PubMed ID: 22641480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.
    Rajabpour A; Afgar A; Mahmoodzadeh H; Radfar JE; Rajaei F; Teimoori-Toolabi L
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):765-775. PubMed ID: 28887583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment.
    Réjiba S; Wack S; Aprahamian M; Hajri A
    Cancer Sci; 2007 Jul; 98(7):1128-36. PubMed ID: 17489984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines.
    Huanwen W; Zhiyong L; Xiaohua S; Xinyu R; Kai W; Tonghua L
    Mol Cancer; 2009 Dec; 8():125. PubMed ID: 20021699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway.
    Jiang J; Bai J; Qin T; Wang Z; Han L
    J Cell Mol Med; 2020 May; 24(10):5901-5910. PubMed ID: 32294802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Feb; 23(8):1539-48. PubMed ID: 14661056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.